Lewis KH, Moore JB, Ard JD
They inhibit the enzyme DPP-4, thus impairing the rapid degradation of two key incretin hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Boss said that, because of the pattern they are noticing in their clinic, she feels patients should only have access to these drugs with clinical supervision, and that they should "undergo a psychological assessment first." Mixed Evidence and Ongoing Research Paul Kenny, director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai, New York, told Newsweek that he believed GLP-1s have "the potential to produce both positive and negative effects on mental well-being, depending on the individual, the dose, and the brain systems being engaged." He pointed to emerging research on the ability of these drugs to reduce craving and compulsive behaviors relating to food, nicotine, alcohol, and potentially other substances
Addiction causes neglect of children or dependents, relationship breakdowns, and conflicts due to behavioral changes
Vet Parasitol 178(12):1521 Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation
Research published in the American Journal of Respiratory and Critical Care Medicine has found that people with asthma and chronic obstructive pulmonary disease (COPD) often show significantly lower glutathione levels in their airway fluid compared to healthy individuals
